SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-034266
Filing Date
2024-03-20
Accepted
2024-03-20 17:10:17
Documents
13
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A crbp-20231231.htm   iXBRL 10-K/A 446978
2 EX-31.1 crbp-ex31_1.htm EX-31.1 13648
3 EX-31.2 crbp-ex31_2.htm EX-31.2 13220
  Complete submission text file 0000950170-24-034266.txt   3022030

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crbp-20231231.xsd EX-101.SCH 1711685
17 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20231231_htm.xml XML 10788
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37348 | Film No.: 24768533
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)